We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug News
    • Trending
    • Commercial Operations
    • GMPs, Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Drug Daily Bulletin
    • Drug Industry Daily
  • Device News
    • Trending
    • Commercial Operations
    • Inspections and Audits
    • Postmarket Safety
    • Quality
    • Regulatory Affairs
    • Research and Development
    • Submissions and Approvals
    • FDAnews Device Daily Bulletin
    • FDAnews Device Daily Bulletin Premium
  • Books
    • FDAnews Books Library
    • Drug Books
    • Device Books
  • Training/Events
    • Webinar Training Pass
    • Events
  • Resources
    • Form 483s Database
    • FDA Approved Drugs
    • eCFR and Guidances
    • White Papers
  • CenterWatch
  • About Us
    • The Company
    • Contact Us
  • Advertising
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » TransEnterix Reports Success in Preclinical Robotic Surgical Procedures

TransEnterix Reports Success in Preclinical Robotic Surgical Procedures

TransEnterix Logo
December 19, 2014

Robotics and flexible instrument devicemaker TransEnterix said Friday that surgeons have successfully completed four general surgery and urology procedures using the company’s SurgiBot patient-side robotic surgery system.

The procedures — two gallbladder removals and two  kidney removals — will serve as a basis for a 510(k) submission in mid-2015, the Durham, N.C., company said.

The system comprises multiple instruments and a camera, operable through a small incision in the patient’s body, giving surgeons enhanced vision, dexterity and control, explains Juan-Carlos Verdeja with Baptist Health Medical Group in Miami, who used the device in the two gallbladder procedures. “Being able to perform the procedure from within the sterile field, and with tactile feedback, increases the control a surgeon has when performing surgery,” he adds.

Michael Ferrandino, of Duke University, who performed the nephrectomies, says the system could be useful in a wide range of surgical procedures. “This system provides an elegant and effective combination of the best of single-port, laparoscopic and robotic approaches in surgery,” he says. — Kellen Owings

Subscribe to Devices & Diagnostics Letter for complete coverage of the medical devices industry. Click here for more information.

Devices Research and Development

Upcoming Events

  • 04Apr

    Optimizing Quality Control Operations with Unified Quality

  • 20Apr

    Medical Device Enforcement: Latest Developments from the FDA, DOJ and FTC

  • 25Apr

    Effective Root Cause Analysis and CAPA Investigations for Drugs, Devices and Clinical Trials

  • 27Apr

    Califf’s FDA, 2023 and Beyond: Key Developments, Insights and Analysis

  • 17May

    2023 WCG Avoca Quality Consortium Summit

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • Prolira’s Beside EEG Monitor Cleared for Acute Brain Failure

  • Britain’s Pharma Association Suspends Novo Nordisk’s Membership

  • Cotras Gets FDA Approval of Virtual Reality Rehab Device

  • FDA Approves Novartis Treatment Combination for Pediatric Glioma

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing